about
Felodipine β-cyclodextrin complex as an active core for time delayed chronotherapeutic treatment of hypertension.Stability studies of microparticulate system with piroxicam as model drug.Nanolipidgel for enhanced skin deposition and improved antifungal activity.Serratiopeptidase loaded chitosan nanoparticles by polyelectrolyte complexation: in vitro and in vivo evaluation.Niosomes as a vesicular carrier for topical administration of minoxidil: formulation and in vitro assessment.Fabrication of isradipine nanosuspension by anti-solvent microprecipitation-high-pressure homogenization method for enhancing dissolution rate and oral bioavailability.Nanosuspension based in situ gelling nasal spray of carvedilol: development, in vitro and in vivo characterization.Niosomal gel of lornoxicam for topical delivery: in vitro assessment and pharmacodynamic activity.Zero order controlled release delivery of cholecalciferol from injectable biodegradable microsphere: In-vitro characterization and in-vivo pharmacokinetic studies.Glucosamine anchored cancer targeted nano-vesicular drug delivery system of doxorubicin.Medium chain triglyceride (MCT) rich, paclitaxel loaded self nanoemulsifying preconcentrate (PSNP): a safe and efficacious alternative to Taxol.Design and evaluation of Lumefantrine - Oleic acid self nanoemulsifying ionic complex for enhanced dissolution.Preparation and characterization of solid lipid nanoparticle-based nasal spray of budesonide.Development, characterisation and evaluation of supersaturated triglyceride free drug delivery (s-TFDDS) of lornoxicam.Bioavailability, bioequivalence, and in vitro-in vivo correlation of oxybutynin transdermal patch in rabbits.Rivastigmine-loaded L-lactide-depsipeptide polymeric nanoparticles: decisive formulation variable optimization.Efficacy Interactions of PEG-DOX-N-acetyl Glucosamine Prodrug Conjugate for Anticancer Therapy.Nanosponge formulations as oxygen delivery systems.Cyclodextrin-based nanosponges encapsulating camptothecin: physicochemical characterization, stability and cytotoxicity.Amorphous ternary cyclodextrin nanocomposites of telmisartan for oral drug delivery: improved solubility and reduced pharmacokinetic variability.Effect of permeation enhancers on dynamic mechanical properties of acrylate pressure sensitive adhesives.Effect of Lipid Composition in Propofol Formulations: Decisive Component in Reducing the Free Propofol Content and Improving Pharmacodynamic Profiles.Nose to Brain Delivery of Rivastigmine by In Situ Gelling Cationic Nanostructured Lipid Carriers: Enhanced Brain Distribution and Pharmacodynamics.Rivastigmine-loaded in situ gelling nanostructured lipid carriers for nose to brain delivery.Novel bilayer dissolving microneedle arrays with concentrated PLGA nano-microparticles for targeted intradermal delivery: Proof of concept.Development and characterization of an organic solvent free, proliposomal formulation of Busulfan using quality by design approach.Novel L-lactide-depsipeptide polymeric carrier for enhanced brain uptake of rivastigmine in treatment of Alzheimer's disease.Rational Design of Cholesterol Derivative for Improved Stability of Paclitaxel Cationic Liposomes.In Vivo Anticancer Efficacy and Toxicity Studies of a Novel Polymer Conjugate N-Acetyl Glucosamine (NAG)-PEG-Doxorubicin for Targeted Cancer Therapy.Dodecylamine Template-Based Hexagonal Mesoporous Silica (HMS) as a Carrier for Improved Oral Delivery of Fenofibrate.Supercritical processed starch nanosponge as a carrier for enhancement of dissolution and pharmacological efficacy of fenofibrate.Oral delivery of paclitaxel nanocrystal (PNC) with a dual Pgp-CYP3A4 inhibitor: preparation, characterization and antitumor activityCyclodextrin nanosponges as effective gas carriersEncapsulation of Acyclovir in new carboxylated cyclodextrin-based nanosponges improves the agent's antiviral efficacyFabrication and statistical optimization of a polysaccharide-based sublingual film of buprenorphine hydrochloride for breakthrough pain management: in vitro and in vivo performanceGlucosamine-anchored doxorubicin-loaded targeted nano-niosomes: pharmacokinetic, toxicity and pharmacodynamic evaluationLiposils: An effective strategy for stabilizing Paclitaxel loaded liposomes by surface coating with silicaArginolipid: A membrane-active antifungal agent and its synergistic potential to combat drug resistance in clinical Candida isolatesCationic cholesterol derivative efficiently delivers the genes: in silico and in vitro studiesSynthesis, Characterization, and Drug Delivery Application of Self-assembling Amphiphilic Cyclodextrin
P50
Q30597071-27DC38BF-90CE-4A39-A001-87C81174EDEAQ33573452-BDE0CB00-84A9-407A-8CD6-243612296FB9Q34319312-61420C15-6457-48ED-9077-526AFE1441D2Q35024353-88664774-CB2E-401C-A9F7-A6CE1181754AQ35580702-79C22D6E-8571-4F5E-8D89-DF6898657288Q35580982-433A8297-E504-4050-BF30-A82E0083A36FQ36636492-E82F8D88-8B9A-4159-9E46-B9610D2FF84AQ37126399-109B8C93-20BE-47D9-AE20-96149DE0254FQ38718612-3B01BFB2-F354-4C04-B9CC-5A63CFF35E42Q38855594-10770C07-5E07-4C79-A392-7033248677B7Q39058280-31A06457-70E1-47AD-90DF-DA0635713079Q40098763-6D9D39E4-5924-4102-B4B4-0B68AAA843D0Q41195499-27231EEC-CC6D-4782-9A28-B1D47200BA0DQ41195506-CC84E1A8-A92D-469D-801C-88AF49C4E555Q41197304-E44B0BB8-EDD9-46FA-A00D-D1801252AE16Q42256432-B4618BAE-9467-4A01-BC7E-59966827AF88Q42817564-C8AAF99F-D255-48E9-8CA8-0763911EF454Q42871431-EE311D89-9C03-44AD-A617-48293FAB1814Q43245503-00E092F6-E5C0-41B2-89C7-0F9176241406Q45259631-37A533CE-FC5A-4156-A1D9-AC028C89B296Q46592716-7F685997-C9DA-4AD5-9271-B18A232A3084Q47443485-674C8909-E24E-40A3-AE6E-87E3BD2952D6Q48107351-DCFD60AD-09EA-42DB-8718-2035EA20D69AQ48555286-B3C7A42E-5CE0-4E59-8424-4753A9BE6F63Q48629660-5D311D47-50C1-405F-824E-6B7430D278C0Q50064758-D175AF46-D25C-4E58-82FC-57879B15E6F3Q50853253-8D9702DE-C004-4A40-82DC-CC0DDBD83FA3Q52665499-3EE1A9C3-CAE8-4913-95ED-6C32A0800252Q53298099-4895A3D8-D8FF-4405-8A62-95AF993E71B9Q53393880-732225E5-CBC7-4F80-A01F-324E31AAA704Q53461469-DFC494BB-CC51-4C63-93BF-4A655ABBF049Q57109360-FEBC2D00-394E-4A81-A1F3-C603704BFDE9Q60169034-5BF4261D-4B81-4D28-BAD5-5E9840D66F5CQ85823756-86A96FE6-7AFA-4B3B-9800-C0A1765B1972Q86953275-0AB656F2-08F9-41A8-B140-4A3BE5EFB49EQ87294495-4396AE89-FE25-4E07-B468-FF4A45295CF5Q89217766-4AB195D7-97B4-4866-8E1E-A9F0777118BEQ90831025-6B6882E7-E427-49E0-9013-DCB3F6633E83Q91072599-FC940167-1E0E-46EE-BF22-FFEDD7880310Q91745193-5B3EAF28-229C-435A-851A-223A66661D9C
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Pradeep R Vavia
@ast
Pradeep R Vavia
@en
Pradeep R Vavia
@es
Pradeep R Vavia
@nl
type
label
Pradeep R Vavia
@ast
Pradeep R Vavia
@en
Pradeep R Vavia
@es
Pradeep R Vavia
@nl
prefLabel
Pradeep R Vavia
@ast
Pradeep R Vavia
@en
Pradeep R Vavia
@es
Pradeep R Vavia
@nl
P106
P1153
56265942900
P31
P496
0000-0001-8568-7857